198 related articles for article (PubMed ID: 9147026)
1. Mipafox differential inhibition assay for heart muscle cholinesterases: substrate specificity and inhibition of three isoenzymes by physostigmine and quinidine.
Chemnitius JM; Haselmeyer KH; Gonska BD; Kreuzer H; Zech R
Gen Pharmacol; 1997 Apr; 28(4):567-75. PubMed ID: 9147026
[TBL] [Abstract][Full Text] [Related]
2. Organophosphate inhibition of human heart muscle cholinesterase isoenzymes.
Chemnitius JM; Sadowski R; Winkel H; Zech R
Chem Biol Interact; 1999 May; 119-120():183-92. PubMed ID: 10421452
[TBL] [Abstract][Full Text] [Related]
3. Cholinesterases of heart muscle. Characterization of multiple enzymes using kinetics of irreversible organophosphorus inhibition.
Chemnitius JM; Chemnitius GC; Haselmeyer KH; Kreuzer H; Zech R
Biochem Pharmacol; 1992 Feb; 43(4):823-9. PubMed ID: 1540236
[TBL] [Abstract][Full Text] [Related]
4. Indirect parasympathomimetic activity of metoclopramide: reversible inhibition of cholinesterases from human central nervous system and blood.
Chemnitius JM; Haselmeyer KH; Gonska BD; Kreuzer H; Zech R
Pharmacol Res; 1996; 34(1-2):65-72. PubMed ID: 8981558
[TBL] [Abstract][Full Text] [Related]
5. Indirect parasympathomimetic activity of the class III antiarrhythmic substance D/L-sotalol in vitro: reversible inhibition of cholinesterase isoenzymes from blood and the human central nervous system.
Chemnitius JM; Schahmirzadi F; Gonska BD; Kreuzer H; Zech R
Pharmacol Res; 1996; 34(5-6):193-200. PubMed ID: 9076843
[TBL] [Abstract][Full Text] [Related]
6. In vitro characterization of cholinesterases in the earthworm Eisenia andrei.
Caselli F; Gastaldi L; Gambi N; Fabbri E
Comp Biochem Physiol C Toxicol Pharmacol; 2006 Aug; 143(4):416-21. PubMed ID: 16753348
[TBL] [Abstract][Full Text] [Related]
7. Computerized analysis of covalent inhibition kinetics for identification of heart muscle cholinesterase and brain carboxylesterase isoenzymes. Design of differential inhibition assays.
Chemnitius JM; Dewald K; Kreuzer H; Zech R
Chem Biol Interact; 1993 Jun; 87(1-3):239-44. PubMed ID: 8343980
[TBL] [Abstract][Full Text] [Related]
8. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
9. Protection from quinidine or physostigmine against in vitro inhibition by sarin of acetylcholinesterase activity.
Singh AK; Zeleznikar RJ; Drewes LR
Life Sci; 1986 Jan; 38(2):165-72. PubMed ID: 3945161
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of human erythrocyte acetylcholinesterase inhibition by a novel derivative of physostigmine: phenserine.
al-Jafari AA; Kamal MA; Greig NH; Alhomida AS; Perry ER
Biochem Biophys Res Commun; 1998 Jul; 248(1):180-5. PubMed ID: 9675107
[TBL] [Abstract][Full Text] [Related]
11. Brain cholinesterases. Differentiation of target enzymes for toxic organophosphorus compounds.
Chemnitius JM; Haselmeyer KH; Zech R
Biochem Pharmacol; 1983 Jun; 32(11):1693-9. PubMed ID: 6870909
[TBL] [Abstract][Full Text] [Related]
12. Species- and concentration-dependent differences of acetyl- and butyrylcholinesterase sensitivity to physostigmine and neostigmine.
Bitzinger DI; Gruber M; Tümmler S; Michels B; Bundscherer A; Hopf S; Trabold B; Graf BM; Zausig YA
Neuropharmacology; 2016 Oct; 109():1-6. PubMed ID: 26772968
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the decarbamoylation rates of physostigmine-inhibited plasma and red cell cholinesterases of man with other species.
Wetherell JR; French MC
Biochem Pharmacol; 1991 Jul; 42(3):515-20. PubMed ID: 1907148
[TBL] [Abstract][Full Text] [Related]
14. Evolution of acetylcholinesterase and butyrylcholinesterase in the vertebrates: an atypical butyrylcholinesterase from the Medaka Oryzias latipes.
Pezzementi L; Nachon F; Chatonnet A
PLoS One; 2011 Feb; 6(2):e17396. PubMed ID: 21364766
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of aging of mipafox-inhibited butyrylcholinesterase.
Kropp TJ; Richardson RJ
Chem Res Toxicol; 2007 Mar; 20(3):504-10. PubMed ID: 17323978
[TBL] [Abstract][Full Text] [Related]
16. Kinetic analysis of inhibition of brain and red blood cell acetylcholinesterase and plasma cholinesterase by acephate or methamidophos.
Singh AK
Toxicol Appl Pharmacol; 1985 Nov; 81(2):302-9. PubMed ID: 4060156
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of two different cholinesterases by tacrine.
Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
[TBL] [Abstract][Full Text] [Related]
18. Estimation of cholinesterase activity (EC 3.1.1.7; 3.1.1.8) in undiluted plasma and erythrocytes as a tool for measuring in vivo effects of reversible inhibitors.
Thomsen T; Kewitz H; Pleul O
J Clin Chem Clin Biochem; 1988 Jul; 26(7):469-75. PubMed ID: 3065439
[TBL] [Abstract][Full Text] [Related]
19. The inhibition of frog tissue cholinesterases and the influence of eserine and prostigmine on the action of acetylcholine on the frog heart.
Majcen Z; Brzin M
Biochem Pharmacol; 1975 Sep; 24(17):1599-602. PubMed ID: 1081394
[No Abstract] [Full Text] [Related]
20. Electrophysiological estimation of the actions of acetylcholinesterase inhibitors on acetylcholine receptor and cholinesterase in physically isolated Aplysia neurones.
Oyama Y; Hori N; Evans ML; Allen CN; Carpenter DO
Br J Pharmacol; 1989 Mar; 96(3):573-82. PubMed ID: 2720293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
